ArticleOncology letters2026

Preliminary study on the efficacy of pazopanib combined with toripalimab as first-line therapy for metastatic renal cell carcinoma: Real-world data from a single center.

Bin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.